文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

中国ICU中Sepsis-1与Sepsis-3诊断标准性能比较:一项回顾性多中心研究

Comparison of the Performance Between Sepsis-1 and Sepsis-3 in ICUs in China: A Retrospective Multicenter Study.
PubMed 文献 · Shock · 2017-01-01
一句话结论在中国ICU感染患者中,Sepsis-3的SOFA评分预测28天死亡的AUROC优于Sepsis-1的SIRS评分(0.69 vs 0.55,P=0.008)。

该回顾性多中心研究纳入2016年5月1日至6月1日5所大学附属医院6个ICU连续收治的496例患者,比较Sepsis-1与Sepsis-3诊断标准性能。496例中186例(37.5%)符合Sepsis-1诊断,175例(35.3%)符合Sepsis-3诊断。在感染患者中,SIRS预测28天死亡的AUROC显著小于SOFA(0.55 vs 0.69,P=0.008)。11例(5.9%)感染患者符合Sepsis-1但不符合Sepsis-3,其APACHE II、SOFA评分及死亡率均显著低于两标准均符合者。作者结论为Sepsis-3在本研究样本中性能优于Sepsis-1。

要点

  • 感染患者中SOFA预测28天死亡的AUROC为0.69(95%CI 0.61-0.77),显著高于SIRS的0.55(95%CI 0.46-0.64),P=0.008。
  • 496例ICU患者中,186例(37.5%)符合Sepsis-1诊断,175例(35.3%)符合Sepsis-3诊断。
  • 11例(5.9%)感染患者符合Sepsis-1但不符合Sepsis-3,其APACHE II为8.6±3.5、SOFA为1(0-1)、死亡率为0.0%。
  • 两标准均符合的脓毒症患者APACHE II为16.3±6.2、SOFA为6(4-8)、死亡率为33.1%,均显著高于仅符合Sepsis-1的11例患者(P分别<0.001、<0.001、=0.019)。
  • 脓毒症患者的APACHE II、ICU住院时间及28天死亡率随SOFA评分升高而逐渐升高,但未随SIRS评分升高而升高。

适用人群与场景

  • 中国5所大学附属医院6个ICU于2016年5月1日至2016年6月1日连续收治的496例患者。

诊断标准与关键阈值

  • Sepsis-1诊断依据SIRS标准,Sepsis-3诊断依据SOFA评分标准。
  • 以28天死亡率为预测终点,比较SIRS与SOFA的AUROC。

研究设计与关键结果

  • 研究类型为回顾性多中心研究,纳入6个ICU连续收治的496例患者,数据取自电子临床记录。
  • 496例中186例(37.5%)符合Sepsis-1诊断,175例(35.3%)符合Sepsis-3诊断。
  • 感染患者中SIRS预测28天死亡的AUROC为0.55(95%CI 0.46-0.64),SOFA为0.69(95%CI 0.61-0.77),SIRS显著小于SOFA(P=0.008)。
  • 11例(5.9%)感染患者符合Sepsis-1但不符合Sepsis-3,其APACHE II为8.6±3.5、SOFA为1(0-1)、死亡率为0.0%。
  • 两标准均符合的脓毒症患者APACHE II为16.3±6.2、SOFA为6(4-8)、死亡率为33.1%,均显著高于仅符合Sepsis-1的11例患者(P分别<0.001、<0.001、=0.019)。
  • 脓毒症患者的APACHE II、ICU住院时间及28天死亡率随SOFA评分升高而逐渐升高,但未随SIRS评分升高而升高。

证据类型、等级与局限

  • 证据类型:回顾性多中心研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,在本研究中国ICU样本中Sepsis-3性能优于Sepsis-1。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

The definition of sepsis was updated to sepsis-3 in February 2016. However, the performance of the previous and new definition of sepsis remains unclear in China. This was a retrospective multicenter study in six intensive care unit (ICUs) from five university-affiliated hospitals to compare the performance between sepsis-1 and sepsis-3 in China. From May 1, 2016 to June 1, 2016, 496 patients were enrolled consecutively. Data were extracted from the electronic clinical records. We evaluated the performance of sepsis-1 and sepsis-3 by measuring the area under the receiver operating characteristic curves (AUROC) to predict 28-day mortality rates. Of 496 enrolled patients, 186 (37.5%) were diagnosed with sepsis according to sepsis-1, while 175 (35.3%) fulfilled the criteria of sepsis-3. The AUROC of systemic inflammatory response syndrome (SIRS) is significantly smaller than that of sequential organ failure assessment (SOFA) (0.55 [95% confidence interval, 0.46-0.64] vs. 0.69 (95% confidence interval, 0.61-0.77], P = 0.008) to predict 28-day mortality rates of infected patients. Moreover, 5.9% infected patients (11 patients) were diagnosed as sepsis according to sepsis-1 but not to sepsis-3. The APACHE II, SOFA scores, and mortality rate of the 11 patients were significantly lower than of patients whose sepsis was defined by both the previous and new criteria (8.6±3.5 vs. 16.3±6.2, P = < 0.001; 1 (0-1) vs. 6 (4-8), P = <0.001; 0.0 vs. 33.1%, P = 0.019). In addition, the APACHE II, length of stay in ICU, and 28-day mortality rate of septic patients rose gradually corresponding with the raise in SOFA score (but not the SIRS score). Sepsis-3 performed better than sepsis-1 in the study samples in ICUs in China.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Cheng B, Li Z, Wang J, et al. Comparison of the Performance Between Sepsis-1 and Sepsis-3 in ICUs in China: A Retrospective Multicenter Study. Shock. 2017. PMID: 28448400. doi:10.1097/SHK.0000000000000868

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。